NF2 and schwannoma: Moreover, Neurofibromatosis type 2 patients with schwannoma, a clinical manifestation of the disorder, accumulate high levels of β-catenin, further indicating that elevated WNT/ β-catenin signaling activity is associated with deficient Merlin expression [21].